Navigation Links
Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
Date:6/25/2008

- Once-daily dosing with enteric-coated tablet produced robust antiviral

activity - - RDEA806 was well tolerated during one week of dosing in HIV patients -

SAN DIEGO, June 25 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced additional positive results from its completed Phase 2a proof-of-concept monotherapy study of RDEA806, its novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in patients with human immunodeficiency virus (HIV).

These additional results demonstrated that once-daily dosing with the enteric-coated tablet formulation of RDEA806 resulted in significant reductions in plasma viral load that were consistent with results previously presented with twice-daily dosing of the capsule formulation in the same study. All dosing regimens tested in the study were well tolerated. Ardea's lead investigator plans to present the full data from this study at a medical conference later this year.

"RDEA806's robust antiviral potency, combined with its excellent tolerability profile in over 130 healthy volunteers and HIV-infected patients treated in clinical studies to-date, make RDEA806 a promising candidate for further investigation as a first-line agent for the treatment of HIV," said Dr. Graeme Moyle, Director of HIV Research, Chelsea and Westminster Hospital, and a lead investigator in the completed Phase 2a trial and planned Phase 2b study.

Phase 2a Clinical Trial Design & Top-line Results

The Phase 2a randomized, double-blind, placebo-controlled trial evaluated the antiviral activity, pharmacokinetics, safety and tolerability of once- and twice-daily oral dosing regimens of RDEA806 versus placebo in 48 HIV-pos
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
11. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... BOSTON , Aug. 29, 2014   Vittamed Corporation ... Boston announced today that T. (Teo) Forcht ... to the company,s Board of Directors. " ... distinguished career in neurosurgery, medical innovation and venture capital," said ... are extremely delighted to add his clinical, strategic, and entrepreneurial ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will ... the Australian and New Zealand Forensic Science Society,s ... Sciences in Adelaide, Australia . ... concerning the advancements that hyperspectral imaging can bring ... Jeffrey Beckstead , Director of Product Development at ...
(Date:8/29/2014)... PASO ROBLES, Calif. , Aug. 29, 2014 /PRNewswire/ ... launch of its new website design . The ... an overhaul that showcases the company,s new services and ... By implementing a new streamlined design, viewers can ... deliver metrics for health care practices and create a ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3PMDS Announces New Website 2
... Acquire Next Generation Molecule GRC 6211 for the Potential ... Treatment of Pain, Including Osteoarthritic Pain, INDIANAPOLIS and MUMBAI, ... ) today announced that it has entered into an,agreement with ... Limited India (GPL). Under the terms,of the agreement, Lilly will ...
... MedImmune today announced,results from a recent economic ... is the standard of care for prevention of,severe ... virus,(RSV) in high- risk infants. Released at the ... Exhibition, the analysis evaluated the,costs of providing Synagis ...
Cached Medicine Technology:Lilly and Glenmark Pharmaceuticals Announce License Agreement 2Lilly and Glenmark Pharmaceuticals Announce License Agreement 3Lilly and Glenmark Pharmaceuticals Announce License Agreement 4Lilly and Glenmark Pharmaceuticals Announce License Agreement 5MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV 2MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV 3
(Date:9/1/2014)... 01, 2014 Registration is now open for ... and 1-Mile Race to be held on Sunday, September 21, ... Yard at Harmon Meadow in Secaucus, New Jersey. All proceeds ... national nonprofit dedicated to restoring a sense of self, restoring ... and our military families. , General registration is $30 with ...
(Date:9/1/2014)... 01, 2014 The Outlier Series announced ... exclusive interview content from one of the exceptional women ... Outliers: Women Game Changers . The title of the ... Game Changer Jenny McClendon . McClendon is currently a ... formerly the star of WeTV show, Raising Sextuplets. , ...
(Date:9/1/2014)... September 01, 2014 Beginning Tuesday, September ... 3,000 medical professionals and 10,000 consumers for the annual ... 5-day gathering of the nation’s top medical professionals who ... or conditions. The week-long event contains more than 120 ... instruction available in the pain management field. , MarijuanaDoctors.com ...
(Date:8/31/2014)... 31, 2014 MYMOBILEUNI (MMU) strategy ... social media marketing tools access to digital, resources, ... will utilize all tools to reach and collaborate ... our multiple learning channels. , MMU, today announced ... an authoring tool that applies social networking concepts ...
(Date:8/31/2014)... 01, 2014 GoDaddy, IX Web ... provide VPS (Virtual Private Server) hosting, which is ... into many servers, each of which has the ... dedicated computer. Top10BestSEOHosting.com has recently compared many professional ... companies are the best VPS hosting suppliers in ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3Health News:GoDaddy, IX Web Hosting and Bluehost Are Awarded As Hosting Experts by Top10BestSEOHosting.com 2
... New Building provides Medical Office space for Doctors, Healthcare ... Specialists, and Medical Professionals, ... for medical space in the Near West Suburban market with ... square,feet of class A, medical office space available in Oakbrook ...
... September 2007. New Phase II data presented today suggest ... treatment of men with Hormone Resistant Prostate Cancer (HRPC), ... men with metastatic HRPC who were asymptomatic or mildly ... experienced a 45 percent reduction in the risk of ...
... Than Half Find Sex Lives Exciting, ATLANTA, Sept. ... themselves (i), but less than one hour on foreplay ... their love lives as,exciting. And while there are ... quality and quantity. On average, Americans spend 35 ...
... the country,s,largest hot tub retailer, announced that it ... give specially-designed therapeutic hot tubs to in 2008.,Through ... will donate 12,ThermoSpas hot tubs -- one a ... warm water therapy. ThermoSpas encourages parents, teachers and,friends ...
... PRAI ) announced today that it plans to relocate ... area by the end of,2007. "The current headquarters ... operational functions," said Terrance J.,Bieker, chief executive officer. "After ... the Raleigh area will allow,PRA to tap into a ...
... Selects Ericom(R) PowerTerm(R) WebConnect for ... ... Health Partners, a,New York-based non-profit hospital system, has chosen PowerTerm ... to,provide doctors and staff with secure, on-demand remote access to ...
Cached Medicine News:Health News:Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 2Health News:Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 3Health News:Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054 2Health News:Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054 3Health News:Americans Not Making Time for Making Love 2Health News:Americans Not Making Time for Making Love 3Health News:Americans Not Making Time for Making Love 4Health News:Photos: America's Chronically Ill Children Have New Hope with 'Hot' Gift 2Health News:PRA International Relocating Headquarters to Raleigh 2Health News:PRA International Relocating Headquarters to Raleigh 3Health News:Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization 2
The Pe-Plus offers an additional clinical option for replacing the acetabulum....
... Metal material and modularity into ... a fusion of technology and versatility ... for initial and long-term stability, but ... shell and liner options to address ...
Trident Hemispherical Acetabular Shells are a true hemispherical shape designed to achieve press-fit fixation by under-reaming the acetabulum....
The Bofor acetabular revision cup addresses cases of severe acetabular destruction....
Medicine Products: